Hadassah

Oral Insulin Pill, Based on Hadassah Medical Center Research, Cleared by FDA for Clinical Trial in US

Tuesday, May 21 2013

The oral insulin pill (ORMD-0801), based on over 30 years of research by Hadassah Medical Center scientists, and developed by the Israeli company, Oramed Pharmaceuticals Inc., has been cleared by the United States Food and Drug Administration (FDA) for Phase 2 clinical trials in the US.

The orally ingestible capsule is indicated for those with early stage type two diabetes, when it can slow the rate of disease progression by providing additional insulin to the body and allowing the pancreas a respite. The pill delivery system has the advantage of mimicking insulin's natural location and gradients in the body by first passing through the liver before entering the bloodstream. "We are very pleased to have the FDA clearance to proceed," stated Nadav Kidron, Chief Executive Officer of Oramed. "The upcoming trial is a major milestone for Oramed and we look forward to continuing to progress ORMD-0801's clinical development in the US."

Read more about the insulin pill from Hadassah International>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Sep 28 2016

Hadassah Medical Organization Goes on High Alert for Peres Funeral

Thousands of visitors, including high profile dignitaries, are expected to arrive in Jerusalem for the funeral of past Prime Minister and President Shimon Peres, who will be laid to rest on Friday, September 30.

READ MORE ›
alt_text

Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.

READ MORE ›
alt_text

Monday, Sep 19 2016

Hadassah Hospital Treats Terror Victims After Stabbing Attacks

This last week has brought a burst of terror attacks.

READ MORE ›
alt_text

Thursday, Sep 15 2016

2012 Hadassah Stage-Four Melanoma Patient Thankfully Healthy

"Doctors in Florida who pronounced me ‘soon-dead’ can't believe that I'm healthy today,” said Hadassah melanoma patient Stewart Greenberg.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More